塞法胺-阿维巴克坦在多药耐药的克莱布西拉菌种中的作用. 感染:单一疗法与联合疗法一样有效吗?
Rukiyye Bulut1, İbrahim Erayman1, Bahar Kandemir1
1Department of Infectious Diseases and Clinical Microbiology, Necmettin Erbakan University Faculty of Medicine, Konya 42080, Türkiye.
Antibiotics (Basel, Switzerland)
|February 27, 2026
概括
塞法胺-阿维巴克坦 (CZA) 在治疗耐卡巴因克莱布西拉 (CRK) 感染方面表现出良好的结果. 治疗的持续时间,而不是组合与单一治疗,在现实环境中显著影响患者的治疗结果.
科学领域:
- 传染性疾病 传染性疾病
- 临床药房 临床药房
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 耐卡巴尼姆的克莱布塞拉 (CRK) 种类是难以治疗的医疗保健相关感染的主要原因.
- 与CRK感染相关的高死亡率需要有效的治疗选择.
研究的目的:
- 评估在患有CRK感染的患者中治疗塞夫塔齐迪姆-阿维巴克坦 (CZA) 的临床结果.
- 为了比较CZA单一治疗与CRK感染的组合治疗的疗效.
主要方法:
- 追溯分析99名患有CRK阳性培养的患者,接受CZA治疗至少72小时.
- 收集的数据包括患者人口统计,并发病,感染类型,CZA治疗方案和临床结果.
- 统计分析的重点是影响临床结果的因素,包括治疗持续时间和治疗方案类型.
主要成果:
- 大多数患者 (89.9%) 处于重症监护室,最常见的感染类型是血液感染和呼吸机相关的肺炎.
- 总体治疗成功率为76.8%,临床改善在3.4天,微生物根除在4.7天.
- 治疗持续时间是影响临床结果的唯一重要因素 (p < 0.001);在CZA单一治疗和组合治疗之间没有显著差异.
结论:
- 塞法胺-阿维巴克坦 (CZA) 是在现实临床环境中有效治疗耐卡巴胺克莱布西拉 (CRK) 感染的疗法.
- 治疗持续时间是CZA治疗的CRK感染中成功结果的关键决定因素.
- 这些发现支持CZA在管理严重CRK感染方面的作用,并为抗菌药物管理策略提供信息.
相关概念视频
Combined Effects of Drugs: Synergism
7.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.1K
Antimicrobial Effectiveness
1.4K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.4K
Acute Pyelonephritis II: Diagnostic Studies and Management
532
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
532
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
232
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
232


